Drug-Coated Balloons Market - Global Industry Analysis

Drug-Coated Balloons Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Healthcare Report Format : PDF Report Code: ZMR-6001 Status : Upcoming

Description

Global Drug-Coated Balloons Market: Overview

A drug-coated balloon is utilized in the treatment of vascular diseases. These balloons are covered with lipophilic anti-proliferative drugs. During inflation of the balloon, the medicine is released to the vessel walls as soon as the drug-coated balloon reaches the vessel. The benefit of drug-coated balloons is that it delivers the drug to vessels homogeneously and protects neointimal hyperplasia. Nominal pressure is applied to inflate the balloons and deliver the medicine.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Drug-Coated Balloons Market: Growth Factors

One of the major factors driving the global drug-coated balloons market is the growing geriatric population across the world. Moreover, a large pool of patients suffering from cardiovascular diseases in developing countries is creating huge demand for the treatment through drug-coated balloons. The increase in adoption of angioplasty procedure due to its minimally invasive nature along with the surging technological advancements in the treatment method is fuelling the growth of the global drug-coated balloons market. The rising development in imaging technologies and the emergence of advanced products are further bolstering the growth of the global drug-coated balloons market. The constantly growing investments to boost the research and development activities to innovate new products in the global drug-coated balloons market are significantly driving the growth of the market globally.

Global Drug-Coated Balloons Market: Segmentation

The global drug-coated balloons market can be segmented into indication, end-user, drug type, and region.

By indication, the market can be segmented into PAD, CAD, and others. Peripheral artery disease (PAD) holds the largest share in the global drug-coated balloons market owing to the wide availability of clinical data supporting the safety of the technology.

By end-user, the market can be segmented into freestanding cath labs, ambulatory care services, and hospitals. The hospitals account for the largest share in the global drug-coated balloons market owing to the rising visit of patients suffering from cardiovascular disease. Moreover, the freestanding cath labs segment is anticipated to witness huge growth during the forecast period due to its added advantages to patients suffering from cardiovascular disease along with financial benefits to the healthcare professionals.

By drug type, the market can be segmented into sirolimus and paclitaxel. The paclitaxel segment holds hegemony over others. The dominance can be attributed to the high utilization of these drugs as they are considered to be highly effective and safe in treating AV, CVS, and urological disorders.

Global Drug-Coated Balloons Market: Regional analysis

North America accounts for the largest share in the global drug-coated balloons market due to the presence of a large population suffering from cardiovascular diseases. The regional market is expected to witness huge growth during the forecast period owing to the expansion of commercialized DCBs, availability of large clinical evidences, new product approvals, and many more. The outcome of different clinical trials conducted in the region is encouraging physicians to adopt DCBs to treat arterial diseases. Moreover, the growing utilization of DCBs is anticipated to proliferate significantly in the coming years owing to the wide availability of positive clinical data that is supporting the efficacy and safety of DCB technology. The rising number of CVD and ESRD patient pools along with the need to treat the disease with the endovascular procedure is likely to fuel the regional market during the forecast period.

Global Drug-Coated Balloons Market: Competitive Players

Some of the significant players in the global drug-coated balloons market are Welling, Urotronic, Terumo, Surmodics, STENTYS, RD Global-Invamed, QT Vascular, Nano Therapeutics, Meril Life Sciences, M.A. Med Alliance, iVascular, HEXACATH, ENDOCOR, eucatech, Concept Medical, Cardionovum, Biosensors International Group, AR Baltic Medical, Acotec Scientific, Aachen Resonance, B. Braun Melsungen AG, Cook Medical, Boston Scientific Corporation, Medtronic Plc, Innvolution Healthcare Pvt. Ltd., BIOTRONIK SE & Co. KG, Terumo Corporation, Opto Circuits, Concept Medical Inc., Koninklijke Philips N.V., Medtronic Plc., Spectranetics, EuroCor, Abbott Laboratories, Cordis Corporation, Cook Medical INC, and Tokai Medical Products Inc.

Global Drug-Coated Balloons Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

One of the major factors driving the global drug-coated balloons market is the growing geriatric population across the world. Moreover, a large pool of patients suffering from cardiovascular diseases in developing countries is creating huge demand for the treatment through drug coated balloons. The constantly growing investments to boost the research and development activities to innovate new products in the global drug-coated balloons market are significantly driving the growth of the market globally.

 

Some of the significant players in the global drug-coated balloons market are Welling, Urotronic, Terumo, Surmodics, STENTYS, RD Global-Invamed, QT Vascular, Nano Therapeutics, Meril Life Sciences, M.A. Med Alliance, iVascular, HEXACATH, ENDOCOR, eucatech, Concept Medical, Cardionovum, Biosensors International Group, AR Baltic Medical, Acotec Scientific, Aachen Resonance, B. Braun Melsungen AG, Cook Medical, Boston Scientific Corporation, Medtronic Plc, and Innvolution Healthcare Pvt. Ltd.

North America accounts for the largest share in the global drug-coated balloons market due to the presence of a large population suffering from cardiovascular diseases. The regional market is expected to witness huge growth during the forecast period owing to the expansion of commercialized DCBs, availability of large clinical evidences, new product approvals, and many more.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed